Jul 13 2021 |
Judge Wipes Out “Wet Ones” False Advertising Suit |
Proskauer Rose LLP |
Jul 13 2021 |
Compliance Date for Final Rule on Gluten-Free Labeling of Fermented and Hydrolyzed Foods Approaches |
Keller and Heckman LLP |
Jul 13 2021 |
FTC Finalizes Made in USA Labeling Rule |
Keller and Heckman LLP |
Jul 12 2021 |
While Legislative Hurdles Remain, We Take a Look at North Carolina’s Medical Marijuana Bill |
Womble Bond Dickinson (US) LLP |
Jul 12 2021 |
FDA Issues TOR Exemption for Metal Carbides in Food Processing Equipment |
Keller and Heckman LLP |
Jul 12 2021 |
DOE Announces Phase I Selections For WTE Technical Assistance |
Bergeson & Campbell, P.C. |
Jul 12 2021 |
JUUL Enters Into Consent Judgment with North Carolina |
Keller and Heckman LLP |
Jul 12 2021 |
NYC Businesses: Do You Have Your “biometric Identifier Collection” Notice Up? |
Mintz |
Jul 12 2021 |
FDA Issues New Draft Guidance on Imported Food |
Keller and Heckman LLP |
Jul 12 2021 |
Biden Executive Order Addresses Healthcare Industry Competition, Targets Pharmaceuticals, Pricing, and Hospital Mergers |
Nelson Mullins |
Jul 9 2021 |
New Yorkers Support Icon for Sugary Menu Items |
Keller and Heckman LLP |
Jul 9 2021 |
South Korean Study Indicates that Food Contact Plastic Materials are Properly Controlled by Existing Regulations |
Keller and Heckman LLP |
Jul 9 2021 |
Bipartisan Legislation Proposed to Authorize CBD Dietary Supplements and Food Additives |
Beveridge & Diamond PC |
Jul 9 2021 |
NanoHarmony Survey Asks Stakeholders about Their Experiences with OECD Test Guidelines and Guidance Documents |
Bergeson & Campbell, P.C. |
Jul 9 2021 |
Commission Launches EU Code of Conduct on Responsible Food Business and Marketing Practices |
Keller and Heckman LLP |
Jul 9 2021 |
FDA Adds Three New Substances to its Inventory of Effective FCS Notifications - July 8, 2021 |
Keller and Heckman LLP |
Jul 9 2021 |
Latest Open Payments Data Released Under Heightened Government Scrutiny |
Foley & Lardner LLP |
Jul 8 2021 |
340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case |
K&L Gates LLP |
Jul 8 2021 |
The Re-Emergence of Ecstasy – But Not at the Club |
Womble Bond Dickinson (US) LLP |
Jul 8 2021 |
Oregon Temporarily Allows Vaccine Incentives and Hiring Bonuses |
Jackson Lewis P.C. |
Jul 8 2021 |
Cannabis Directors and Officers Liability: Cause for Optimism? |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Jul 8 2021 |
Nature’s Path Sued for Overstating Protein |
Keller and Heckman LLP |
Jul 8 2021 |
China’s National Intellectual Property Administration Releases Patent Linkage Administrative Adjudication Measures |
Schwegman, Lundberg & Woessner, P.A. |
Jul 8 2021 |
Transparency in Prescription Drug Pricing: Recent State and Federal Developments to Watch |
Greenberg Traurig, LLP |
Jul 7 2021 |
340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements |
K&L Gates LLP |
Jul 7 2021 |
Mexico’s Supreme Court Finds General Health Law Articles Prohibiting Recreational Use of Marijuana Unconstitutional |
Greenberg Traurig, LLP |
Jul 7 2021 |
House Asks FDA to Clarify Plant-Based Food Labels |
Keller and Heckman LLP |
Jul 6 2021 |
The Supreme Court of Justice Authorized the Recreational Use of Cannabis |
OLIVARES |
Jul 6 2021 |
China Releases Patent Linkage Implementation Measures |
Schwegman, Lundberg & Woessner, P.A. |
Jul 6 2021 |
EC Requests Scientific Opinion on Fullerenes and Hydroxylated Fullerenes |
Bergeson & Campbell, P.C. |
Jul 6 2021 |
7th Circuit Affirms Summary Judgment in Favor of Defendant Champion Petfoods |
Keller and Heckman LLP |
Jul 2 2021 |
340B Drug Pricing Discount Program Update: HRSA Now Demands That Drug Manufacturers Provide 340B Discounts To Contract Pharmacies Amid Ongoing Litigation |
Sheppard, Mullin, Richter & Hampton LLP |
Jul 2 2021 |
FDA Releases Cyclospora Action Plan |
Keller and Heckman LLP |
Jul 1 2021 |
More than Innovation and Competition: The Latest Proposed Monitoring and Enforcement Mechanisms Targeting Foreign Influence in U.S. Research |
K&L Gates LLP |
Jul 1 2021 |
Failure To State Cost Of Confirmatory Re-Test Violates Iowa Drug Testing Law |
Jackson Lewis P.C. |